PragmaClin is a Canadian MedTech company transforming neurological care through PRIMS® (PragmaClin Intelligent Motor System), an AI-driven, depth camera-based assessment platform. Designed to address the critical gaps in neurological diagnosis and monitoring, PRIMS® automates the clinical evaluation of motor symptoms starting with Parkinson’s disease. PRIMS® enables objective, standardized, and remote assessments aligned with MDS-UPDRS scales. The platform supports clinicians, hospitals, and researchers with real-time insights, reducing the subjectivity, cost, and delay associated with current evaluations. PRIMS® is validated through global partnerships, including studies in North America, Europe, and Asia, and is advancing through a De Novo FDA regulatory pathway. Scalable to other motor conditions, PRIMS® represents the future of decentralized, equitable, and data-driven neurological care.